About Luqa Pharma
Luqa Pharma is a company based in Shanghai (China) founded in 2010 was acquired by China Medical System in February 2021.. Luqa Pharma has raised $30 million across 2 funding rounds from investors including China Medical System, Cenova and Morningside China. Luqa Pharma operates in a competitive market with competitors including Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series B
Feb 06, 2018
-
Investors
China Medical System
& 2 more
-
Employee Count
Employee Count
-
Acquired by
China Medical System
(Feb 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Luqa Pharma
Luqa Pharma has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $15.0M
-
First Round
First Round
(09 Jun 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2018 | Amount | Series B - Luqa Pharma | Valuation | Cenova |
|
| Jun, 2015 | Amount | Series A - Luqa Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Luqa Pharma
Luqa Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include China Medical System, Cenova and Morningside China. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
VC and private equity investments are made in China-US companies.
|
Founded Year | Domain | Location | |
|
Generic formulations including tablets, capsules, liquids, and injectables are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Luqa Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Luqa Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Luqa Pharma Comparisons
Competitors of Luqa Pharma
Luqa Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| domain | founded_year | HQ Location |
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics in aesthetics are developed, including botulinum toxin products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Luqa Pharma
Frequently Asked Questions about Luqa Pharma
When was Luqa Pharma founded?
Luqa Pharma was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Where is Luqa Pharma located?
Luqa Pharma is headquartered in Shanghai, China.
Is Luqa Pharma a funded company?
Luqa Pharma is a funded company, having raised a total of $30M across 2 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Jun 09, 2015.
What does Luqa Pharma do?
Luqa Pharma was founded in 2010 in Shanghai, China, within the pharmaceutical sector. Operations focus on developing therapeutic products for scars, skin infections, repair, and wound healing. Key offerings include Strataderm gel for scar treatment, planned for launch in 2016, Endocare for skin repair, and Laluxid as a non-antibiotic device for infections. Regulatory approvals have been obtained in Europe, the USA, and China.
Who are the top competitors of Luqa Pharma?
Luqa Pharma's top competitors include Revance Therapeutics, Dermavant and Bausch Health.
Who are Luqa Pharma's investors?
Luqa Pharma has 3 investors. Key investors include China Medical System, Cenova, and Morningside China.